Heart Failure after Aortic Valve Replacement: Incidence, Risk Factors, and Implications

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Heart Failure Research

Background:

• Severe aortic stenosis (AS) significantly worsens prognosis, especially with heart failure (HF) symptoms, necessitating aortic valve replacement (AVR).
• Transcatheter aortic valve replacement (TAVR) has revolutionized AS management, enabling treatment for high-risk surgical candidates.
• Despite improved survival, residual HF symptoms and hospitalizations post-TAVR are common, impacting mortality and health status.

Purpose of the Study:

• To review the incidence and risk factors associated with heart failure following aortic valve replacement (AVR).
• To highlight the need for improved strategies in preventing and managing post-AVR heart failure.
• To explore the potential benefits of earlier AVR intervention to mitigate adverse outcomes.

Main Methods:

• Literature review focusing on studies examining heart failure incidence and risk factors after surgical and transcatheter AVR.
• Analysis of current management strategies for heart failure in patients who have undergone AVR.
• Discussion of emerging research on the timing of AVR and its impact on long-term outcomes.

Main Results:

• Heart failure symptoms and hospitalizations remain prevalent after AVR, including TAVR, correlating with increased mortality.
• Identified risk factors contribute to the development or persistence of HF post-AVR.
• Early AVR intervention prior to severe symptoms and extra-valvular damage is being investigated for improved outcomes.

Conclusions:

• Effective management of heart failure post-AVR is crucial for enhancing patient survival and quality of life.
• Further research into risk factor modification and optimal timing for AVR is warranted.
• Optimizing care pathways for AS patients undergoing AVR is essential to address residual HF challenges.